Search

Your search keyword '"Kevin D. Read"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Kevin D. Read" Remove constraint Author: "Kevin D. Read"
111 results on '"Kevin D. Read"'

Search Results

1. Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

2. Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

3. Targeting N-myristoylation for therapy of B-cell lymphomas

4. Temporal and Wash-Out Studies Identify Medicines for Malaria Venture Pathogen Box Compounds with Fast-Acting Activity against Both Trypanosoma cruzi and Trypanosoma brucei

5. Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice

6. A Systematic Study of the In Vitro Pharmacokinetics and Estimated Human In Vivo Clearance of Indole and Indazole-3-Carboxamide Synthetic Cannabinoid Receptor Agonists Detected on the Illicit Drug Market

7. Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition

8. Sperm Toolbox-A selection of small molecules to study human spermatozoa.

9. Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022

11. Sperm Toolbox – A selection of small molecules to study human spermatozoa

12. Preparation, biological evaluation and QSAR analysis of urea substituted 2,4-diamino-pyrimidine anti-malarials

13. Male contraceptive development: A medicinal chemistry perspective

14. Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis

15. Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

16. The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis

17. Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity

18. Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis

19. Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis

20. Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target

21. Compounds enhancing human sperm motility identified using a high-throughput phenotypic screening platform

22. Substituted Aminoacetamides as Novel Leads for Malaria Treatment

23. A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites

24. Author Correction: Anti-trypanosomatid drug discovery: progress and challenges

25. Identification and development of a series of disubstituted piperazines for the treatment of Chagas disease

26. Preparation, biologicalcheminformatics-based assessment of N

27. Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy

28. Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs

29. Targeting N-myristoylation for therapy of B-cell lymphomas

30. Discovery and Optimization of a Compound Series Active against

31. Setting our sights on infectious diseases

32. Discovery and Optimization of a Compound Series Active against Trypanosoma cruzi, the Causative Agent of Chagas Disease

33. Para-Site-Seeing

34. 2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas’ disease

35. Optimization of a 'bump-and-hole' approach to allele-selective BET bromodomain inhibition

36. Preparation, biological & cheminformatics-based assessment of N2,N4-diphenylpyrimidine-2,4-diamine as potential Kinase-targeted antimalarials

37. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi

38. Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis

39. Abstract 5156: Targeting N-myristoylation in B-cell lymphomas as a therapeutic strategy

40. Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani

41. A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors

42. Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future

43. Discovery of super soft-drug modulators of sphingosine-1-phosphate receptor 1

44. Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users

45. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors

46. Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani

47. The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1

48. Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

49. Antitrypanosomatid drug discovery: an ongoing challenge and a continuing need

50. Initial Characterization and Toxicology of an Nmt Inhibitor in Development for Hematologic Malignancies

Catalog

Books, media, physical & digital resources